Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Title:
Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial
Author:
Salvador Bofill, Javier Moreno Anton, Fernando Rodriguez Sanchez, Cesar Augusto Galve Calvo, Elena Hernando Melia, Cristina Ciruelos Gil, Eva Maria Vidal, Maria Jiménez-Rodriguez, Begoña De la Cruz Merino, Luis Martínez Jañez, Noelia Villanueva Vazquez, Rafael de Toro Salas, Ruben Anton Torres, Antonio Alvarez Lopez, Isabel Manuela Gavila Gregori, Joaquin Quiroga Garcia, Vanesa Vicente Rubio, Elena De la Haba-Rodriguez, Juan Gonzalez-Santiago, Santiago Diaz Fernandez, Nieves Barnadas Molins, Agusti Cantos Sanchez de Ibargüen, Blanca Delgado Mingorance, Juan Ignacio Bellet Ezquerra, Meritxell de Casa, Sonia Gimeno, Asuncion Martin, Miguel